Irritable Bowel Syndrome-Global Market Status and Trend Report 2014-2026

Table of Contents
Chapter 1 Overview of Irritable Bowel Syndrome
    1.1 Definition of Irritable Bowel Syndrome in This Report
    1.2 Commercial Types of Irritable Bowel Syndrome
        1.2.1 IBS-D Drug
        1.2.2 IBS-C Drug
        1.2.3 Others
    1.3 Downstream Application of Irritable Bowel Syndrome
        1.3.1 Women
        1.3.2 Men
    1.4 Development History of Irritable Bowel Syndrome
    1.5 Market Status and Trend of Irritable Bowel Syndrome 2014-2026
        1.5.1 Global Irritable Bowel Syndrome Market Status and Trend 2014-2026
        1.5.2 Regional Irritable Bowel Syndrome Market Status and Trend 2014-2026
Chapter 2 Global Market Status and Forecast by Regions
    2.1 Market Development of Irritable Bowel Syndrome 2014-2019
    2.2 Production Market of Irritable Bowel Syndrome by Regions
        2.2.1 Production Volume of Irritable Bowel Syndrome by Regions
        2.2.2 Production Value of Irritable Bowel Syndrome by Regions
    2.3 Demand Market of Irritable Bowel Syndrome by Regions
    2.4 Production and Demand Status of Irritable Bowel Syndrome by Regions
        2.4.1 Production and Demand Status of Irritable Bowel Syndrome by Regions 2014-2019
        2.4.2 Import and Export Status of Irritable Bowel Syndrome by Regions 2014-2019
Chapter 3 Global Market Status and Forecast by Types
    3.1 Production Volume of Irritable Bowel Syndrome by Types
    3.2 Production Value of Irritable Bowel Syndrome by Types
    3.3 Market Forecast of Irritable Bowel Syndrome by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
    4.1 Demand Volume of Irritable Bowel Syndrome by Downstream Industry
    4.2 Market Forecast of Irritable Bowel Syndrome by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Irritable Bowel Syndrome
    5.1 Global Economy Situation and Trend Overview
    5.2 Irritable Bowel Syndrome Downstream Industry Situation and Trend Overview
Chapter 6 Irritable Bowel Syndrome Market Competition Status by Major Manufacturers
    6.1 Production Volume of Irritable Bowel Syndrome by Major Manufacturers
    6.2 Production Value of Irritable Bowel Syndrome by Major Manufacturers
    6.3 Basic Information of Irritable Bowel Syndrome by Major Manufacturers
        6.3.1 Headquarters Location and Established Time of Irritable Bowel Syndrome Major Manufacturer
        6.3.2 Employees and Revenue Level of Irritable Bowel Syndrome Major Manufacturer
    6.4 Market Competition News and Trend
        6.4.1 Merger, Consolidation or Acquisition News
        6.4.2 Investment or Disinvestment News
        6.4.3 New Product Development and Launch
Chapter 7 Irritable Bowel Syndrome Major Manufacturers Introduction and Market Data
    7.1 Valeant Pharmaceuticals
        7.1.1 Company profile
        7.1.2 Representative Irritable Bowel Syndrome Product
        7.1.3 Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of Valeant Pharmaceuticals
    7.2 Allergan
        7.2.1 Company profile
        7.2.2 Representative Irritable Bowel Syndrome Product
        7.2.3 Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of Allergan
    7.3 Takeda
        7.3.1 Company profile
        7.3.2 Representative Irritable Bowel Syndrome Product
        7.3.3 Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of Takeda
    7.4 Sucampo Pharmaceuticals
        7.4.1 Company profile
        7.4.2 Representative Irritable Bowel Syndrome Product
        7.4.3 Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of Sucampo Pharmaceuticals
    7.5 McNeil Consumer Healthcare
        7.5.1 Company profile
        7.5.2 Representative Irritable Bowel Syndrome Product
        7.5.3 Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of McNeil Consumer Healthcare
    7.6 Sebela Pharmaceuticals
        7.6.1 Company profile
        7.6.2 Representative Irritable Bowel Syndrome Product
        7.6.3 Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of Sebela Pharmaceuticals
    7.7 Astellas Pharmaceuticals
        7.7.1 Company profile
        7.7.2 Representative Irritable Bowel Syndrome Product
        7.7.3 Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of Astellas Pharmaceuticals
    7.8 IM HealthScience
        7.8.1 Company profile
        7.8.2 Representative Irritable Bowel Syndrome Product
        7.8.3 Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of IM HealthScience
Chapter 8 Upstream and Downstream Market Analysis of Irritable Bowel Syndrome
    8.1 Industry Chain of Irritable Bowel Syndrome
    8.2 Upstream Market and Representative Companies Analysis
    8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Irritable Bowel Syndrome
    9.1 Cost Structure Analysis of Irritable Bowel Syndrome
    9.2 Raw Materials Cost Analysis of Irritable Bowel Syndrome
    9.3 Labor Cost Analysis of Irritable Bowel Syndrome
    9.4 Manufacturing Expenses Analysis of Irritable Bowel Syndrome
Chapter 10 Marketing Status Analysis of Irritable Bowel Syndrome
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Reference